BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study
| Image |  |
|---|---|
| Description | scientific article published on 03 December 2020 |
| Author/s |
author: Jorge Eduardo Cortes Avichai Shimoni James M Foran Naveen Pemmaraju |
| Publication date | December 3, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |